INS and cystic fibrosis-related diabetes: Some studies reported that CFRD patients have lower GIP and GLP-1 levels than patients without diabetes and control groups [62], and this could contribute to the postprandial glycemic variability present in CFRD, associated with impaired first-phase insulin release [63].